KCCC_Logo
STAFF EMAIL
Email Center
Patients & Families

Patients & Their Families

Being diagnosed with cancer is a challenge. Promise us, you'll always remember: you are BRAVER than you believe, STRONGER than you seem, SMARTER than you think, and twice as beautiful as you'd ever imaged.

Frequently asked questions (FAQ)

About Cancer

Know more about different cancer types

The State of Kuwait has been targeting to eliminate cancer, and it shows in our commitment to enhance cancer care service and comprehensive educational programs to enable our patients & their families to join the fight to end cancer.

Screening Programs

Screening & Early diagnosis

The State of Kuwait stressed the importance of developing awareness on the environmental causes of some cancers, and strategic interventions within national action plans to address the harmful effects on health. Kuwait has successfully implemented the National Program for Early Diagnosis of Colorectal Cancer and the early diagnosis program for breast cancer among women.

Our Partners

The Ministry Of Health in the State of Kuwait collaborates with other entities to provide clinical expertise to Kuwait Cancer Control Center (KCCC) and strengthen cancer service delivery at the KCCC. Through this collaboration, KCCC offers our patients an access to the best internationally-certified cancer services, while ensuring continuous improvement of cancer care in Kuwait. We also focus on improving nursing and physician education, health administration and information technology. We continue to expand our experience internationally while developing systems and innovative approaches that would benefit our patients.

For Experts

Doctor's Guide

Doctor's Guide will show all medical oncologists what to look for in a practice, how to provide a high class medical service, and how to integrate the decision support tools into the daily practice.

Image
Image
أرقام التواصل عن طريق الواتسآب
WhatsApp Numbers
قسم طب الأورام
Medical Oncology

98944785

قسم العلاج الاشعاعي
Radiation Therapy

98943084

قسم أمراض الدم
Hematology Department

55876714

قسم جراحة الأورام
Surgical Oncology

98944807

الصيدلية
Pharmacy

96735242

قسم الأشعة التشخيصية
Radiology Department

98944746

قسم الطب النووي
Nuclear Medicine

98944794

العلاج الطبيعي
Physical Therapy

98945546

Image
Image
أرقام التواصل عن طريق الواتسآب
WhatsApp Numbers
قسم طب الأورام
Medical Oncology

98944785

قسم العلاج الاشعاعي
Radiation Therapy

98943084

قسم أمراض الدم
Hematology Department

55876714

قسم جراحة الأورام
Surgical Oncology

98944807

الصيدلية
Pharmacy

96735242

قسم الأشعة التشخيصية
Radiology Department

98944746

قسم الطب النووي
Nuclear Medicine

98944794

العلاج الطبيعي
Physical Therapy

98945546

Image
  • FLUCIS-00-04-04-RT
    5-Fluorouracil / CISplatin ± Radiotherapy
    FLUCIS-00-04-04-RT,Fluorouracil,5FU,5-FU,Cisplatin,Radiotherapy,Radiation,-GI
  • FUFA-0000-04-06-GI
    5-Fluorouracil / Folinic acid
    FUFA-0000-04-06-GI,Fluorouracil,5FU,5-FU
  • FUFA-0000-04-05-RT
    5-Fluorouracil / Folinic acid + Radiotherapy
    FUFA-0000-04-05-RT,Fluorouracil,5FU,5-FU,Radiotherapy,Radiation,-GI
  • FLUMTO-00-04-02-RT
    5-Fluorouracil / mitoMYcin + Radiotherapy
    FLUMTO-00-04-02-RT,Fluorouracil,5FU,5-FU,Mitomycin,Radiotherapy,Radiation,-GI
  • AC-000000-02-04-BR
    AC (Dose Dense)
    AC-000000-02-04-BR,AC,Adriamycin,DOXOrubicin,Cyclophosphaime
  • AC-000000-03-04-BR
    AC
    AC-000000-03-04-BR,AC,Adriamycin,DOXOrubicin,Cyclophosphaime
  • TDM1-0000-03-CN-BR
    ado-TRASTuzumab Emtansine
    TDM1-0000-03-CN-BR,ado-TRASTuzumab
  • AFA-00000-DL-CN-TX
    AFAtinib (Giotrif®)
    AFA-00000-DL-CN-TX,AFAtinib,Giotrif
  • ALC-00000-DL-CN-TX
    ALECtinib (Alecensa®)
    ALC-00000-DL-CN-TX,ALECtinib,Alecensa
  • ANA-00000-DL-CN-BR
    ANAStrozole (Arimidex®)
    ANA-00000-DL-CN-BR,ANAStrozole
  • ATZBEV-00-03-CN-ML
    ATEZOlizumab / BEVAcizumab
    ATZBEV-00-03-CN-ML,BEVAcizumab,Avastin,ATEZOlizumab,Tecentriq,-TX,-GI
  • ATZ-00000-03-CN-ML
    ATEZOlizumab (Tecentriq®)
    ATZ-00000-03-CN-ML,ATEZOlizumab,Tecentriq,-TX,-HN,-GU
  • BEP-00000-03-04-GU
    BEP (BLEOmycin / Etoposide / CISplatin)
    BEP-00000-03-04-GU,BEP
  • BEV5-0000-02-CN-GI
    BEVAcizumab (5 mg/kg every 2 weeks)
    BEV5-0000-02-CN-GI,BEVAcizumab
  • BEV75-000-03-CN-GI
    BEVAcizumab (7.5 mg/kg every 3 weeks)
    BEV75-000-03-CN-GI,BEVAcizumab
  • BEV10-000-02-CN-ML
    BEVAcizumab (10 mg/kg every 2 weeks)
    BEV10-000-02-CN-ML,BEVAcizumab,-GI,-GY
  • BEV15-000-03-CN-ML
    BEVAcizumab (15 mg/kg every 3 weeks)
    BEV15-000-03-CN-ML,BEVAcizumab,-TX,-GY
  • BEVIRI125-02-CN-GY
    BEVAcizumab / IRINotecan 125
    BEVIRI125-02-CN-GY,BEVAcizumab,Avastin,IRINotecan
  • BEVIRI340-02-CN-GY
    BEVAcizumab / IRINotecan 340
    BEVIRI340-02-CN-GY,BEVAcizumab,Avastin,IRINotecan
  • BEVPCL-00-04-CN-BR
    BEVAcizumab / PACLItaxel
    BEVPCL-00-04-CN-BR,BEVAcizumab,Avastin,PACLItaxel
  • CPZPRE-00-03-CN-GU
    CABAZitaxel / Prednisone
    CPZPRE-00-03-CN-GU,CABAZitaxel,Prednisone
  • CAP-00000-03-06-TX
    CAP (CYCLOPHOSPHamide / ADRIAmycin / Platinol)
    CAP-00000-03-06-TX,CAP,CYCLOPHOSPHamide,DOXOrubicin,Adriamycin,CISplatin
  • CAV-00000-03-06-TX
    CAV (CYCLOPHOSPHamide / ADRIAmycin / vinCRIStine)
    CAV-00000-03-06-TX,CAV,CYCLOPHOSPHamide,DOXOrubicin,Adriamycin,vinCRIStine,-TX
  • XEL-00000-03-CN-ML
    CAPEcitabine (Xeloda®)
    XEL-00000-03-CN-ML,CAPEcitabine,Xeloda,-BR,-GI,-TX
  • XEL-00000-01-05-RT
    CAPEcitabine Concomitant with Radiotherapy
    XEL-00000-01-05-RT,CAPEcitabine,Xeloda,Radiation,Radiotherapy,-GI
  • XELTMZ-00-04-CN-TX
    CAPEcitabine / Temozolomide
    XELTMZ-00-04-CN-TX,CAPEcitabine,Xeloda,Temozolomide
  • CRB-00000-03-06-ML
    CARBOplatin (every 3 weeks)
    CRB-00000-03-06-ML,CARBOplatin,-TX,-GY
  • CRB-00000-04-06-ML
    CARBOplatin (every week)
    CRB-00000-04-06-ML,CARBOplatin,-TX,-GY
  • CRB-00000-04-06-RT
    CARBOplatin Concomitant with Radiotherapy
    CRB-00000-04-06-RT,CARBOplatin,radiation,Radiotherapy
  • CRBVCRCYC-06-04-OT
    CARBOplatin / vinCRIStine / CYCLOPHOSPHamide
    CRBVCRCYC-06-04-OT,CARBOplatin,vinCRIStine,CYCLOPHOSPHamide
  • CER-00000-DL-CN-TX
    CERItinib (Zykadia®)
    CER-00000-DL-CN-TX,CERItinib,Zykadia
  • CTX-00000-02-CN-GI
    CETUximab (every 2 weeks)
    CTX-00000-02-CN-GI,CETUximab
  • CTX-00000-01-CN-ML
    CETUximab (every week)
    CTX-00000-01-CN-ML,CETUximab,-GI,-HN
  • CTX-00000-01-06-RT
    CETUximab Concomitant with Radiotherapy
    CTX-00000-01-06-RT,CETUximab,Radiation,Radiotherapy,-HN
  • CISFLU-00-03-06-HN
    CISplatin / 5-Fluorouracil
    CISFLU-00-03-06-HN,CISplatin,5FU,Fluorouracil,5-Fluorouracil
  • CISIRI-00-04-04-TX
    CISplatin / IRINotecan
    CISIRI-00-04-04-TX,CISplatin,IRINotecan
  • CIS-00000-01-06-RT
    Weekly CISplatin Concomitant with Radiotherapy
    CIS-00000-01-06-RT,CISplatin,radiationRadiotherapy,-HN
  • CMF-00000-03-06-BR
    CMF (CYCLOPHOSPHamide / Methotrexate / 5-Fluorouracil)
    CMF-00000-03-06-BR,CMF,CYCLOPHOSPHamide,Methotrexate,Fluorouracil,5FU,5-Fluorouracil
  • CRZ-00000-DL-CN-TX
    CRIZOtinib (Xalkori®)
    CRZ-00000-DL-CN-TX,CRIZOtinib,Xalkori
  • DCFa-0000-03-06-GI
    DCF (A)
    DCFa-0000-03-06-GI,DCF,DOCEtaxel,CISplatin,Fluorouracil,5FU,5-FU
  • DCFb-0000-02-06-GI
    DCF (B)
    DCFb-0000-02-06-GI,DCF,DOCEtaxel,CISplatin,Fluorouracil,5FU,5-FU
  • deGramont-02-CN-GI
    de Gramont Regimen
    deGramont-02-CN-GI,de Gramont
  • DNO60-000-24-CN-AD
    DENOsumab (Prolia®), every 6 months
    DNO60-000-24-CN-AD,DENOsumab,Prolia
  • DNO120-00-04-CN-AD
    DENOsumab (Xgeva®), monthly
    DNO120-00-04-CN-AD,DENOsumab,Xgeva
  • DOC-00000-03-CN-ML
    DOCEtaxel (3 weeks)
    DOC-00000-03-CN-ML,DOCEtaxel,-TX,-BR,-GU,-SA,-GY
  • DOC-00000-04-CN-ML
    DOCEtaxel (biweekly)
    DOC-00000-04-CN-ML,DOCEtaxel,-TX,-BR,-GU,-SA,-GY
  • DOC-00000-01-CN-ML
    DOCEtaxel (Weekly)
    DOC-00000-01-CN-ML,DOCEtaxel,-TX,-BR,-GU,-SA,-GY
  • DOCCRB-00-03-06-ML
    DOCEtaxel / CARBOplatin (3 weeks)
    DOCCRB-00-03-06-ML,DOCEtaxel,CARBOplatin,-TX,-BR,-GU,-SA
  • DOCCIS-00-03-06-TX
    DOCEtaxel / CISplatin
    DOCCIS-00-03-06-TX,DOCEtaxel,CISplatin
  • DOCCYC-00-03-04-BR
    DOCEtaxel / CYCLOPHOSPHamide
    DOCCYC-00-03-04-BR,DOCEtaxel,CYCLOPHOSPHamide
  • DOCEPI-00-03-06-BR
    DOCEtaxel / EPIrubicin
    DOCEPI-00-03-06-BR,DOCEtaxel,EPIrubicin
  • DOCPRE-00-03-06-GU
    DOCEtaxel / Prednisone
    DOCPRE-00-03-06-GU,DOCEtaxel,Prednisone
  • DOCRMC-00-03-CN-TX
    DOCEtaxel / Ramucirumab
    DOCRMC-00-03-CN-TX,DOCEtaxel,Ramucirumab
  • DOF-00000-03-06-GI
    DOF (DOCEtaxel / OXALIplatin / 5-Fluorouracil)
    DOF-00000-03-06-GI,DOF,DOCEtaxel,OXALIplatin,Fluorouracil,5FU
  • DOX-00000-03-06-SA
    DOXOrubicin (Single-agent)
    DOX-00000-03-06-SA,DOXOrubicin
  • DOXCIS-00-03-06-SA
    DOXOrubicin / CISplatin
    DOXCIS-00-03-06-SA,DOXOrubicin,CISplatin
  • DRV-00000-02-24-ML
    Durvalumab (Imfinzi®)
    DRV-00000-02-24-TX,Durvalumab,Imfinzi
  • EC-000000-03-04-BR
    EC (EPIrubicin / CYCLOPHOSPHamide)
    EC-000000-03-04-BR,EC,EPIrubicin,CYCLOPHOSPHamide
  • ECF-00000-03-08-GI
    ECF (EPIrubicin / CISplatin / 5-Fluorouracil)
    ECF-00000-03-08-GI,ECF,CISplatin,5-FU,Fluorouracil
  • ECX-00000-03-08-GI
    ECX (EPIrubicin / CISplatin / CAPEcitabine)
    ECX-00000-03-08-GI,ECX,EPIrubicin,CISplatin,CAPEcitabine,Xeloda
  • EOF-00000-03-08-GI
    EOF (EPIrubicin / OXALIplatin / 5-Fluorouracil)
    EOF-00000-03-08-GI,EOF,EPIrubicin,OXALIplatin,5-FU,Fluorouracil
  • EOX-00000-03-08-GI
    EOX (EPIrubicin / OXALIplatin / CAPEcitabine)
    EOX-00000-03-08-GI,EOX,EPIrubicin,OXALIplatin,CAPEcitabine,Xeloda
  • EMACO-000-02-06-GY
    EMA-CO
    EMACO-000-02-06-GY,EMA-CO,Etoposide,Methotrexate,ACTINomycin,CYCLOPHOSPHamide,vinCRIStine
  • EPI-00000-03-06-BR
    EPIrubicin
    EPI-00000-03-06-BR,EPIrubicin
  • ERI-00000-03-CN-BR
    eriBULin
    ERI-00000-03-CN-BR,eriBULin
  • ERL-00000-DL-CN-TX
    ERLOtinib (Tarceva®)
    ERL-00000-DL-CN-TX,ERLOtinib,Tarceva
  • ETOCRB-00-03-06-ML
    Etoposide / CARBOplatin
    ETOCRB-00-03-06-ML,Etoposide,CARBOplatin,-TX,-GI,-GU
  • ETOCIS-00-03-06-ML
    Etoposide / CISplatin
    ETOCIS-00-03-06-ML,Etoposide,CISplatin,-TX,-GI,-GU
  • ETOCIS-00-03-02-RT
    Etoposide / CISplatin Concomitant with Radiotherapy
    ETOCIS-00-03-02-RT,Etoposide,CISplatin,Radiation,Radiotherapy,-TX
  • EVE-00000-DL-CN-ML
    Everolimus (Afinitor®)
    EVE-00000-DL-CN-ML,Everolimus,Afinitor,-TX,-BR
  • EXE-00000-DL-CN-BR
    Exemestane (Aromasin®)
    EXE-00000-DL-CN-BR,Exemestane,Aromasin
  • FAC-00000-03-04-BR
    FAC (Fluorouracil / ADRIAmycin / CYCLOPHOSPHamide)
    FAC-00000-03-04-BR,FAC,Fluorouracil,5FU,5-FU,ADRIAmycin,DOXOrubicin,CYCLOPHOSPHamide
  • FEC100-00-03-03-BR
    FEC100 (Fluorouracil / EPIrubicin / CYCLOPHOSPHamide)
    FEC100-00-03-03-BR,FEC100,5FU,5-FU,Fluorouracil,EPIrubicin,CYCLOPHOSPHamide
  • FLOT-0000-02-08-GI
    FLOT (DOCEtaxel / OXALIplatin / 5-Fluorouracil)
    FLOT-0000-03-06-GI,FLOT,DOCEtaxel,OXALIplatin,Fluorouracil,5FU
  • FLOX-0000-08-03-GI
    FLOX (5-Fluorouracil / OXALIplatin)
    FLOX-0000-08-03-GI,FLOX,5FU,5-FU,5-Fluorouracil,OXALIplatin
  • FOLFIRI-0-02-04-GI
    FOLFIRI
    FOLFIRI-0-02-04-GI,FOLFIRI,5-Fluorouracil,IRINotecan
  • COMBINED-02-003-GI
    FOLFIRI + BEVAcizumab
    COMBINED-02-003-GI,BEVAcizumab,FOLFIRI,5-Fluorouracil,IRINotecan
  • COMBINED-02-001-GI
    FOLFIRI + CETUximab
    COMBINED-02-001-GI,CETUximab,FOLFIRI,5-Fluorouracil,IRINotecan
  • FOLFIRINOX-2-12-GI
    FOLFIRINOX (adjuvant, PRODIGE Trial)
    FOLFIRINOX-2-CN-GI,FOLFIRINOX,5-Fluorouracil,5-FU,5FU,OXALIplatin,IRINotecan
  • FOLFIRINOX-2-CN-GI
    FOLFIRINOX (palliative)
    FOLFIRINOX-2-CN-GI,FOLFIRINOX,5-Fluorouracil,5-FU,5FU,OXALIplatin,IRINotecan
  • FOLFOX4-0-02-CN-GI
    FOLFOX 4
    FOLFOX4-0-02-CN-GI,FOLFOX,Fluorouracil,5FU,5-FU,OXALIplatin
  • FOLFOX6-0-02-CN-GI
    FOLFOX 6
    FOLFOX6-0-02-CN-GI,FOLFOX 6,Fluorouracil,5FU,5-FU,OXALIplatin
  • COMBINED-02-006-GI
    FOLFOX 6 + BEVAcizumab
    COMBINED-02-006-GI,BEVAcizumab,FOLFOX 6,Fluorouracil,5FU,5-FU,OXALIplatin
  • COMBINED-02-004-GI
    FOLFOX 6 + CETUximab
    COMBINED-02-004-GI,CETUximab,FOLFOX 6,Fluorouracil,5FU,5-FU,OXALIplatin
  • COMBINED-02-005-GI
    FOLFOX 6 + PANItumumab
    COMBINED-02-005-GI,PANItumumab,FOLFOX 6,Fluorouracil,5FU,5-FU,OXALIplatin
  • FOLFOXIRI-02-04-GI
    FOLFOXIRI
    FOLFOXIRI-02-04-GI,FOLFOXIRI,Fluorouracil,5FU,5-FU,OXALIplatin,IRINotecan
  • FOLFOXIRIBEV-02-04-GI
    FOLFOXIRI + BEVAcizumab (TRIBE Trial)
    FOLFOXIRIBEV-02-04-GI,FOLFOXIRI,Bevacizumab,Tribe,Fluorouracil,5FU,5-FU,OXALIplatin,IRINotecan,-GI
  • FOLFOXIRICTX-02-04-GI
    FOLFOXIRI + CETUximab (MACBETH Trial)
    FOLFOXIRICTX-02-04-GI,FOLFOXIRI, CETUximab ,MACBETH,Fluorouracil,5FU,5-FU,OXALIplatin,IRINotecan
  • FOLFOXIRIPNT-02-04-GI
    FOLFOXIRI + PANItumumab (VOLFI Trial)
    FOLFOXIRIPNT-02-04-GI,FOLFOXIRI,PANItumumab,VOLFI,Fluorouracil,5FU,5-FU,OXALIplatin,IRINotecan
  • FUL-00000-04-CN-BR
    Fulvestrant (Faslodex®)
    FUL-00000-04-CN-BR,Fulvestrant,Faslodex
  • GEF-00000-DL-CN-TX
    GEFitinib (Iressa®)
    GEF-00000-DL-CN-TX,GEFitinib,Iressa
  • GEM-00000-01-05-RT
    GEMcitabine + Radiotherapy
    GEM-00000-01-05-RT,GEMcitabine,Radiotherapy,Radiation,-GI
  • GEM-00000-03-CN-ML
    GEMcitabine (3 weeks)
    GEM-00000-03-CN-ML,GEMcitabine,-TX,-BR,-GI,-GY,-SA
  • GEM-00000-04-CN-ML
    GEMcitabine (4 weeks)
    GEM-00000-04-CN-ML,GEMcitabine,-TX,-BR,-GI,-GY,-SA
  • GEMXEL-00-04-06-GI
    GEMcitabine / CAPEcitabine
    GEMXEL-00-04-06-GI,GEMcitabine,CAPEcitabine,Xeloda
  • GEMCRB-00-03-06-ML
    GEMcitabine / CARBOplatin (3 weeks)
    GEMCRB-00-03-06-ML,GEMcitabine,CARBOplatin,-TX,-BR,-GI,-GY
  • GEMCRB-00-04-06-ML
    GEMcitabine / CARBOplatin (4 weeks)
    GEMCRB-00-04-06-ML,GEMcitabine,CARBOplatin,-TX,-BR,-GI,-GY,-SA
  • GEMCIS-ABC-03-06-GI
    GEMcitabine / CISplatin (ABC-02 Trial)
    GEMCIS-ABC-03-06-GI,ABC-02,GEMcitabine,CISplatin,-GI
  • GEMCIS-00-03-06-ML
    GEMcitabine / CISplatin (3 weeks)
    GEMCIS-00-03-06-ML,GEMcitabine,CISplatin,-TX,-BR,-GI,-GY,-SA
  • GEMCIS-00-04-06-ML
    GEMcitabine / CISplatin (4 weeks)
    GEMCIS-00-04-06-ML,GEMcitabine,CISplatin,-TX,-BR,-GI,-GY,-SA
  • GEMDOC-00-03-06-SA
    GEMcitabine / DOCEtaxel (3 weeks)
    GEMDOC-00-03-06-SA,GEMcitabine,DOCEtaxel
  • GEMDOC-00-04-06-SA
    GEMcitabine / DOCEtaxel (4 weeks)
    GEMDOC-00-04-06-SA,GEMcitabine,DOCEtaxel
  • GEMPCL-00-03-06-GU
    GEMcitabine / PACLItaxel (3 weeks)
    GEMPCL-00-03-06-GU,GEMcitabine,PACLItaxel
  • GEMPCL-00-04-06-BR
    GEMcitabine / PACLItaxel (weekly)
    GEMPCL-00-04-06-BR,GEMcitabine,PACLItaxel
  • GEMViv-00-03-06-ML
    GEMcitabine / VinORELBine
    GEMViv-00-03-06-ML,GEMcitabine,VinORELBine,-TX
  • GEMOX-000-03-06-ML
    GEMOX (GEMcitabine / OXALIplatin)
    GEMOXL-00-03-06-ML,GEMOX,GEMcitabine,Oxaliplatin,-OT,-GI
  • GSR-00000-04-CN-ML
    Goserelin Acetate (Zoladex® 3.6 mg)
    GSR-00000-04-CN-ML,Goserelin,Zoladex,-BR,-GU
  • GSR-00000-12-CN-ML
    Goserelin Acetate (Zoladex® 10.8 mg)
    GSR-00000-12-CN-ML,Goserelin,Zoladex,-BR,-GU
  • HDMTX-000-01-30-SA
    High-dose Methotrexate (MTX)
    HDMTX-000-01-30-SA,High-dose,MTX,Methotrexate
  • ICE-00000-03-06-SA
    ICE (IFOSFamide / CISplatin / EPIrubicin)
    ICE-00000-03-06-SA,ICE,CISplatin,EPIrubicin,IFOSFamide
  • IFOETO-00-03-06-SA
    IE (IFOSFamide / Etoposide)
    IFOETO-00-03-06-SA,IE,IFOSFamide,Etoposide
  • IFOCIS-00-03-06-SA
    IFOSFamide / CISplatin
    IFOCIS-00-03-06-SA,IFOSFamide,CISplatin
  • IMA400-00-DL-CN-SA
    IMAtinib (Gleevec® 400 mg)
    IMA400-00-DL-CN-SA,IMAtinib,Gleevec,-GI,-TX
  • IMA800-00-DL-CN-SA
    IMAtinib (Gleevec® 800 mg)
    IMA800-00-DL-CN-SA,IMAtinib,Gleevec,-GI,-TX
  • BCGi-0000-01-06-GU
    Intravesical BCG (Induction)
    BCGi-0000-01-06-GU,Intravesical,BCG,Induction,-RT
  • BCGm-0000-01-24-GU
    Intravesical BCG (Maintenance)
    BCGm-0000-01-24-GU,Intravesical,BCG,Maintenance,-RT
  • MTOi-0000-01-06-GU
    Intravesical mitoMYcin-C (Induction)
    MTOi-0000-01-06-GU,Intravesical,mitoMYcin-C,Induction,-RT
  • MTOm-0000-04-12-GU
    Intravesical mitoMYcin-C (Maintenance)
    MTOm-0000-04-12-GU,Intravesical,mitoMYcin-C,Maintenance,-RT
  • IPI-00000-03-04-OT
    IPILImumab (Yervoy®)
    IPI-00000-03-04-OT,IPILImumab,Yervoy
  • IRI180-00-02-CN-ML
    IRINotecan (every 2 weeks)
    IRI180-00-02-CN-ML,IRINotecan,-TX,-GI,-GY
  • IRI350-00-03-CN-ML
    IRINotecan (every 3 weeks)
    IRI350-00-03-CN-ML,IRINotecan,-TX,-GI,-GY
  • IRI125-00-01-CN-ML
    IRINotecan (every week)
    IRI125-00-01-CN-ML,IRINotecan,-TX,-GI,-GY
  • IRICRB-00-04-04-TX
    IRINotecan / CARBOplatin
    IRICRB-00-04-04-TX,IRINotecan,CARBOplatin
  • IRICTX-00-02-CN-GI
    IRINotecan / CETUximab
    IRICTX-00-02-CN-GI,IRINotecan,CETUximab
  • IRIDOC-00-03-CN-GI
    IRINotecan / DOCEtaxel
    IRIDOC-00-03-CN-GI,IRINotecan,DOCEtaxel
  • IVA-00000-03-06-SA
    IVA (IFOSFamide / vinCRIStine / ACTINomycin)
    IVA-00000-03-06-SA,IVA,IFOSFamide,vinCRIStine,ACTINomycin
  • IVADo-000-03-06-SA
    IVADo (IFOSFamide / vinCRIStine / ACTINomycin / DOXOrubicin)
    IVADo-000-03-06-SA,IVADo,IFOSFamide / vinCRIStine,ACTINomycin,DOXOrubicin
  • LAP-00000-DL-CN-BR
    LAPAtinib (Tykerb®)
    LAP-00000-DL-CN-BR,LAPAtinib,Tykerb
  • LET-00000-DL-CN-BR
    LEtrozole (Femara®)
    LET-00000-DL-CN-BR,LEtrozole,Femara
  • LOMCISVCR-06-08-OT
    Lomustine / CISplatin / vinCRIstine
    LOMCISVCR-06-08-OT,Lomustine,CISplatin,vinCRIstine
  • MAI-00000-03-06-SA
    MAI (IFOSFamide / Mesna / ADRIAmycin)
    MAI-00000-03-06-SA,MAI,IFOSFamide,ADRIAmycin
  • Mayo-0000-04-06-GI
    Mayo Clinic Regimen
    Mayo-0000-04-06-GI,Mayo Clinic,5-Fluorouracil,5FU,5-FU
  • MGS-00000-DL-CN-ML
    Megestrol Acetate (Megace®)
    MGS-00000-DL-CN-ML,Megestrol,Megace,-AD,-BR
  • MTX-00000-02-06-GY
    Methotrexate / Leucovorin
    MTX-00000-02-06-GY,Methotrexate
  • MdeGramont-2-CN-GI
    Modified de Gramont Regimen
    MdeGramont-2-CN-GI,de Gramont,5-Fluorouracil,5-FU,5FU
  • COMBINED-02-009-GI
    Modified de Gramont Regimen + BEVAcizumab
    MdeGramont,COMBINED-02-009-GI,de Gramont Regimen,BEVAcizumab,FOLFIRI,5-Fluorouracil,IRINotecan
  • COMBINED-02-007-GI
    Modified de Gramont Regimen + CETUximab
    MdeGramont,COMBINED-02-007-GI,de Gramont Regimen,CETUximab,FOLFIRI,5-Fluorouracil,IRINotecan
  • COMBINED-02-008-GI
    Modified de Gramont Regimen + PANItumumab
    MdeGramont,COMBINED-02-008-GI,de Gramont Regimen,PANItumumab,FOLFIRI,5-Fluorouracil,IRINotecan
  • NPCCRB-00-03-04-TX
    NAB-PACLitaxel / CARBOplatin (3 weeks)
    NPCCRB-00-03-04-TX,NAB-PACLitaxel,CARBOplatin,Abraxane
  • NPCGEM-00-04-CN-GI
    NAB-PACLitaxel / GEMcitabine
    NPCGEM-00-04-CN-GI,NAB-PACLitaxel,GEMcitabine,Abraxane
  • NPC-00000-04-CN-ML
    NAB-PACLitaxel
    NPC-00000-04-CN-ML,NAB-PACLitaxel,Abraxane,-TX,BR
  • NIVIPI-00-03-04-OT
    NIVOlumab / IPILImumab (Melanoma)
    NIVIPI-00-03-04-OT,NIVOlumab,IPILImumab
  • NIVIPI-00-06-CN-TX
    NIVOlumab / IPILImumab (Mesothelioma)
    NIVIPI-00-03-04-OT,NIVOlumab,IPILImumab
  • NIV-00000-02-CN-ML
    NIVOlumab (Opdivo®), every 2 weeks
    NIV-00000-02-CN-ML,NIVOlumab,Opdivo,-TX,-HN,-GI,-GU
  • NIV-00000-04-CN-ML
    NIVOlumab (Opdivo®), every 4 weeks
    NIV-00000-02-CN-ML,NIVOlumab,Opdivo,-TX,-HN,-GI,-GU
  • OSI-00000-DL-CN-TX
    OSIMERtinib (Tagrisso™)
    OSI-00000-DL-CN-TX,OSIMERtinib,Tagrisso
  • OXL-00000-03-CN-GI
    OXALIplatin
    OXL-00000-03-CN-GI,OXALIplatin
  • PCL-00000-02-CN-BR
    PACLItaxel (Dose Dense)
    PCL-00000-02-CN-BR,PACLItaxel
  • PCL-00000-04-CN-ML
    PACLItaxel (weekly)
    PCL-00000-04-CN-ML,PACLItaxel,-TX,-BR,-GY
  • PCL-00000-01-12-BR
    PACLItaxel (weekly x 12)
    PCL-00000-01-12-BR,PACLItaxel
  • PCLCRB-00-03-06-ML
    PACLItaxel / CARBOplatin (3 weeks)
    PCLCRB-00-03-06-ML,PACLItaxel,CARBOplatin,-TX,-BR,-GY
  • PCLCRB-00-04-06-ML
    PACLItaxel / CARBOplatin (weekly)
    PCLCRB-00-04-06-ML,PACLItaxel,CARBOplatin,-TX,-BR,-GY
  • PCLCRBBEV-02-06-GY
    PACLItaxel / CARBOplatin / BEVAcizumab
    PCLCRBBEV-02-06-GY,PACLItaxel,CARBOplatin,BEVAcizumab,Avastin
  • PCLCRB-00-01-CN-RT
    PACLItaxel / CARBOplatin Concomitant with Radiotherapy
    PCLCRB-00-01-CN-RT,PACLItaxel,CARBOplatin,Radiotherapy,Radiation,-TX
  • PCLCIS-00-03-06-ML
    PACLItaxel / CISplatin (3 weeks)
    PCLCIS-00-03-06-ML,PACLItaxel,CISplatin,-TX,-BR,-GY
  • PCLRMC-00-04-CN-GI
    PACLItaxel / Ramucirumab (RAINBOW Trial)
    PCLRMC-00-04-CN-GI,PACLItaxel,Ramucirumab
  • PLB-00000-04-CN-BR
    PALBOciclib (Ibrance®)
    PLB-00000-04-CN-BR,PALBOciclib,Ibrance
  • PAN-00000-02-CN-GI
    PANItumumab (Vectibix®)
    PAN-00000-02-CN-GI,PANItumumab,Vectibix
  • PAZ-00000-DL-CN-ML
    PAZOpanib (Votrient®)
    PAZ-00000-DL-CN-ML,PAZOpanib,Votrient,-SA,-GU,-GY
  • CLX-00000-04-CN-ML
    Pegylated Liposomal DOXOrubicin (Caelyx®)
    CLX-00000-04-CN-ML,Pegylated,Liposomal,DOXOrubicin,Caelyx,-TX,-GY
  • CLXCRB-00-04-09-GY
    Pegylated Liposomal DOXOrubicin / CARBOplatin
    CLXCRB-00-04-09-GY,Pegylated,Liposomal,DOXOrubicin,Caelyx,CARBOplatin
  • CLXCYC-00-03-06-BR
    Pegylated Liposomal DOXOrubicin / CYCLOPHOSPHamide
    CLXCYC-00-03-06-BR,Caelyx,Pegylated,Liposomal,DOXOrubicin,CYCLOPHOSPHamide
  • PMB-00000-03-CN-ML
    pemBROLIzumab / 3 weeks
    PMB-00000-02-CN-ML,keytruda,pemBROLIzumab,-TX,-GU
  • PMB-00000-06-CN-ML
    pemBROLIzumab / 6 weeks
    PMB-00000-02-CN-ML,keytruda,pemBROLIzumab,-TX,-GU
  • PEM-00000-03-CN-TX
    Pemetrexed (Alimta®)
    PEM-00000-03-CN-TX,Pemetrexed,Alimta
  • PEMCRB-00-03-06-TX
    Pemetrexed / CARBOplatin
    PEMCRB-00-03-06-TX,Alimta,Pemetrexed,CARBOplatin
  • PEMCIS-00-03-06-TX
    Pemetrexed / CISplatin
    PEMCIS-00-03-06-TX,Alimta,Pemetrexed,CISplatin
  • PRT-00000-03-CN-BR
    PERTuzumab (Perjeta®)
    PRT-00000-03-CN-BR,PERTuzumab,Perjeta
  • RMC-00000-02-CN-GI
    Ramucirumab (Cyramza®)
    RMC-00000-02-CN-GI,Ramucirumab,Cyramza
  • REG-00000-DL-CN-ML
    REGorafinib (Stivarga®)
    REG-00000-DL-CN-ML,REGorafinib,Stivarga,-GI,-SA
  • RBO-00000-04-CN-BR
    RIBOciclib (Kisqali®)
    RBO-00000-04-CN-BR,RIBOciclib,Kisqali
  • SND-00000-04-CN-TX
    Sandostatin LAR
    SND-00000-04-CN-TX,Sandostatin
  • SRF-00000-DL-CN-ML
    Sorafinib (Nexvar®)
    SRF-00000-DL-CN-ML,Sorafinib,Nexvar,-GI,-OT,-SA,-TX
  • SUN375-00-DL-CN-ML
    SUNitinib (Sutent®) 37.5 mg
    SUN375-00-DL-CN-ML,SUNitinib,Sutent,-OT,-TX,-GU,-GI,-SA
  • SUN50-000-DL-CN-OT
    SUNitinib (Sutent®) 50 mg
    SUN50-000-DL-CN-OT,SUNitinib,Sutent,-TX,-GU,-GI,-SA
  • TAM-00000-DL-CN-BR
    Tamoxifen (Nolvadex®-D)
    TAM-00000-DL-CN-BR,Tamoxifen,Nolvadex
  • TCF-00000-03-06-GI
    TCF (TRASTuzumab / CISplatin / 5-Fluorouracil)
    TCF-00000-03-06-GI,TCF,TRASTuzumab,CISplatin,Fluorouracil,5FU,5-FU
  • TMZ-00000-DL-06-RT
    Temozolomide Concomitant with Radiotherapy
    TMZ-00000-DL-06-RT,Temozolomide,Radiotherapy,Radiation,-OT
  • TMZ-00000-04-CN-ML
    Temozolomide
    TMZ-00000-04-CN-ML,Temozolomide,-TX,-OT
  • TIP-00000-03-04-GU
    TIP (PACLItaxel / IFOSFamide / CISplatin)
    TIP-00000-03-04-GU,TIP,PACLItaxel,IFOSFamide,CISplatin
  • TOF-00000-03-06-GI
    TOF (TRASTuzumab / OXALIplatin / 5-Fluorouracil)
    TOF-00000-03-06-GI,TOF,TRASTuzumab,OXALIplatin,Fluorouracil,5FU,5-FU
  • TOP-00000-03-CN-ML
    TOPotecan (3 weeks)
    TOP-00000-03-CN-ML,TOPotecan,-TX,-GI,-GY
  • TOP-00000-04-CN-ML
    TOPotecan (4 weeks)
    TOP-00000-04-CN-ML,TOPotecan,-TX,-GI,-GY
  • TOPCRB-00-03-06-TX
    TOPotecan / CARBOplatin
    TOPCRB-00-03-06-TX,TOPotecan,CARBOplatin
  • TOPCIS-00-04-06-TX
    TOPotecan / CISplatin
    TOPCIS-00-04-06-TX,TOPotecan,CISplatin
  • TPF-00000-03-06-HN
    TPF (DOCEtaxel / CISplatin / 5-Fluorouracil)
    TPF-00000-03-06-HN,TPF,DOCEtaxel,CISplatin,Fluorouracil,5FU,5-FU
  • TRB-00000-03-CN-SA
    Trabectedin (Yondelis®)
    TRB-00000-03-CN-SA,Trabectedin,Yondelis
  • TRTsc-000-03-CN-BR
    TRASTuzumab (SubCut)
    TRTsc-000-03-CN,TRASTuzumab
  • TRTiv-000-03-CN-BR
    TRASTuzumab IV (3 weeks)
    TRTiv-000-03-CN-BR,TRASTuzumab
  • TRTiv-000-01-CN-BR
    TRASTuzumab IV (weekly)
    TRTiv-000-01-CN-BR,TRASTuzumab
  • COMBINED-03-001-BR
    TRASTuzumab + PERTuzumab
    COMBINED-03-001-BR,PERTuzumab,TRASTuzumab
  • TRT-00000-DL-CN-GI
    Trifluridine and Tipiracil (Lonsurf®)
    TRT-00000-DL-CN-GI,Trifluridine,Tipiracil,Lonsurf
  • VAC-00000-03-17-SA
    VAC (VinCRIStine / ACTINomycin / CYCLOPHOSPHamide)
    VAC-00000-03-17-SA,VAC,VinCRIStine,ACTINomycin,CYCLOPHOSPHamide
  • VIDE-0000-03-06-SA
    VIDE
    VIDE-0000-03-06-SA,VIDE,vinCRIStine,IFOSFamide,DOXOrubicin,Adriamycin,Etoposide
  • Vpo-00000-03-CN-BR
    VinORELBine Oral
    Vpo-00000-03-CN-BR,VinORELBine
  • Viv18-000-03-06-ML
    VinORELBine (IV D1, 8)
    Viv18-000-03-06-ML,VinORELBine,-TX,-BR,-GY
  • Viv1815-0-03-06-ML
    VinORELBine (IV D1, 8, 15)
    Viv1815-0-03-06-ML,VinORELBine,-TX,-BR,-GY
  • VivCRB-00-04-04-TX
    VinORELBine / CARBOplatin
    VivCRB-00-04-04-TX,VinORELBine,CARBOplatin
  • VivCIS-00-04-04-TX
    VinORELBine / CISplatin
    VivCIS-00-04-04-TX,VinORELBine,CISplatin
  • VIP-00000-03-06-ML
    VIP (Vepesid / IFOSFamide / Platinol)
    VIP-00000-03-06-ML,VIP,Vepesid,Etoposide,IFOSFamide,Platinol,CISplatin,-TX,-GU,-SA
  • mXELIRI-0-03-CN-GI
    Modified XELIRI (AXEPT Trial)
    mXELIRI-0-03-CN-GI,XELIRI,CAPEcitabine,Xeloda,IRINotecan
  • XELIRI-00-03-CN-GI
    XELIRI (CAPEcitabine / IRINotecan)
    XELIRI-00-03-CN-GI,XELIRI,CAPEcitabine,Xeloda,IRINotecan
  • XELOX-000-03-CN-ML
    XELOX (CAPEcitabine / OXALIplatin)
    XELOX-000-03-CN-ML,XELOX,CAPEcitabine,Xeloda,OXALIplatin,-GI,-TX
  • AFL-00000-02-CN-GI
    Ziv-Aflibercept (Zaltrap®)
    AFL-00000-02-CN-GI,Ziv-Aflibercept,Aflibercept,Zaltrap
  • ZOL4-0000-04-CN-AD
    ZOLEdronic Acid (Zometa®), monthly
    ZOL4-0000-04-CN-AD,ZOLEdronic,Zometa
  • ZOL4-0000-12-CN-AD
    ZOLEdronic Acid (Zometa®), every 3 months
    ZOL4-0000-12-CN-AD,ZOLEdronic,Zometa
  • ZOL4-0000-24-CN-AD
    ZOLEdronic Acid (Zometa®), every 6 months
    ZOL4-0000-24-CN-AD,ZOLEdronic,Zometa
  • ZOL5-0000-52-CN-AD
    ZOLEdronic Acid (Aclasta®), annually
    ZOL5-0000-52-CN-AD,ZOLEdronic,Aclasta
© 2020 Kuwait Cancer Control Center